Articles From: Clinical Study Using Trovagene's Precision Cancer Monitoring Platform Published in Cancer Discovery to AMAG Pharmaceuticals, Inc. to Host Conference Call on October 30, 2014 at 8:00 a.m. ET to Discuss Financial Results for the Quarter and Nine Months Ended September 30, 2014


Prospective blinded study demonstrates ability to accurately determine mutational status and monitor response to BRAF inhibitor therapy from urinary cell-free DNA SAN DIEGO , Oct.
Sign-up for Clinical Study Using Trovagene's Precision Cancer Monitoring Platform Published in Cancer Discovery investment picks
Alibaba (BABA) was started with a buy rating and a $118 price target at Jefferies on Monday, with the brokerage predicting that more than half of China will be using its platforms to make online purchases within the decade.
Sign-up for Alibaba to double Chinese users within the decade investment picks
Third Quarter 2014 Highlights: Continued profitability – annualized return on average assets of 0.97%   Reduced NPAs – nonperforming assets were 0.37% of total assets at September 30, 2014   Strong capital position – Tier 1 common equity to total assets of 9.25% AUBURN, Ala., Oct.
Sign-up for Auburn National Bancorporation, Inc. Reports Third Quarter Net Earnings investment picks
CUPERTINO, Calif.
Sign-up for DURECT Provides Update on REMOXY® and POSIDUR™ Programs investment picks
E*TRADE Financial Corporation (NASDAQ: ETFC) today announced results from the most recent wave of StreetWise , E*TRADE’s quarterly tracking study of experienced investors.
Sign-up for Volatility is the #1 Investor Concern investment picks
Accenture (NYSE:ACN) today announced new industry-leading management capabilities for the Accenture Cloud Platform that give organizations the power and flexibility to manage their workloads simply, effectively and more securely across both on-premise private and public clouds.
Sign-up for New Accenture Cloud Platform Management Capabilities Accelerate Enterprise Migration to the Cloud investment picks
Survey Findings Reveal Incidence of First-Time Reactions in School Setting PITTSBURGH , Oct.
Sign-up for EpiPen4Schools® Program Enhances Support of National Movement to Improve Anaphylaxis Preparedness and Access to Emergency Treatment in Schools investment picks
Crestwood Midstream Partners LP (NYSE: CMLP) (“Crestwood”) announced today the loading of the 1,000 th crude oil unit train at its COLT Hub in Epping, North Dakota.
Sign-up for Crestwood Midstream Partners Announces Loading of 1,000th Unit Train at Its Bakken COLT Hub Facility investment picks
Kofax® Limited (NASDAQ:KFX) LSE:KFX), a leading provider of smart process applications for the business critical First Mile™ of customer interactions, today announced that Kofax Mobile Capture™ Platform received the 2014 Software of the Year Award from Document Manager (DM) Magazine at the Hotel Russell in London’s Russell Square.
Sign-up for Kofax Mobile Capture Platform Wins Document Manager Magazine’s 2014 Software of the Year Award investment picks
VirtuMedix advanced messaging, encryption and navigation capabilities leverage TCS technology expertise ANNAPOLIS, Md.
Sign-up for TeleCommunication Systems Deploys New VirtuMedix™ Healthcare Platform to Improve Patient Care and Reduce Costs investment picks
CACI International Inc ( NYSE:CACI ) announced today it has been awarded a $53 million contract to continue providing systems integration, development, and sustainment for the Theater Enterprise-Wide Logistics System (TEWLS) at the Joint Medical Logistics Functional Development Center (JMLFDC) at Fort Detrick, Md.
Sign-up for CACI Awarded $53 Million Contract to Continue Support for Department of Defense Medical Logistics System investment picks
Pfizer Inc. (NYSE: PFE ) has notified Pain Therapeutics, Inc. (NASDAQ: PTIE ) that it has decided to discontinue its agreement to develop and commercialize REMOXY™ (oxycodone) Extended-Release Capsules CII, an investigational extended-release oral formulation of oxycodone.
Sign-up for Pfizer to Discontinue Agreement on REMOXY™ (oxycodone) Extended-Release Capsules CII investment picks
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for discovery and development, announced that The Dow Chemical Company (NYSE: DOW) has licensed both its best-in-class GastroPlus™ and ADMET Predictor™ software programs.
Sign-up for Dow Chemical Licenses Simulations Plus Software to Assist with Toxicology and Environmental Research investment picks
NEWTON, Mass., Oct.
Sign-up for Karyopharm Expands Global Presence With European Subsidiary investment picks
Microchip Technology Inc. (NASDAQ: MCHP), a leading provider of microcontroller, mixed-signal, analog and Flash-IP solutions, today announced its first App Developer Specialist— WillowTree Apps —the latest company to join Microchip’s world-class Design Partner Network .
Sign-up for Microchip’s First Mobile App Developer Specialist Provides Easy Internet of Things App Creation for Embedded Designers investment picks
Cowen Group, Inc. (“Cowen”) (NASDAQ:COWN) today announced that Oliver Chen has joined Cowen and Company’s Equity Research department as a Managing Director to cover specialty retail, broadlines & department stores, and luxury stocks.
Sign-up for Retail Analyst Oliver Chen Joins Cowen’s Equity Research Department investment picks
FXT Edge Filers and Lattus Enable High-Performance, Cost-Effective Access to Content PITTSBURGH and SAN JOSE, Calif.
Sign-up for Avere and Quantum Team to Optimize Storage for Upstream Workflows in Oil and Gas Exploration investment picks
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval of its TactiCath™ Quartz irrigated ablation catheter, the company’s newest technology that gives physicians a real-time, objective measure of the force that the catheter applies to a patient’s heart wall during an ablation procedure.
Sign-up for St. Jude Medical Receives FDA Approval of TactiCath Quartz Contact Force Ablation Catheter for Treatment of Atrial Fibrillation investment picks
BRIDGEHAMPTON, N.Y., Oct.
Sign-up for Bridge Bancorp, Inc. Reports Third Quarter 2014 Results investment picks
SALT LAKE CITY , Oct.
Sign-up for Zions Bancorporation Board Declares Dividends For Common And Preferred Shares investment picks
Citrix® today announced that NetScaler®, the industry’s most advanced cloud networking platform, has been evaluated and positioned by Gartner, Inc. in the leaders quadrant in the 2014 Magic Quadrant for Application Delivery Controllers [1] (ADC) report authored by Gartner analysts Mark Fabbi and Andrew Lerner for the eighth consecutive year.
Sign-up for Citrix Positioned for the Eighth Consecutive Year in the Leaders Quadrant for Application Delivery Controllers MQ investment picks
NEW YORK, Oct.
Sign-up for Sotheby's Third Quarter 2014 Earnings Conference Call Invitation investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Clinical Study Using Trovagene's Precision Cancer Monitoring Platform Published in Cancer Discovery to AMAG Pharmaceuticals, Inc. to Host Conference Call on October 30, 2014 at 8:00 a.m. ET to Discuss Financial Results for the Quarter and Nine Months Ended September 30, 2014
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent